Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. [NA]
The clinical trial evaluating wide-field OCT with AI to reduce positive margin rates in breast-conserving surgery has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of Paclitaxel Polymeric Micelles for Injection in patients with metastatic br…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Breast Cancer and Breast Self-examination Education [NA]
The clinical trial evaluating education on breast self-examination for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Prospective Multicenter Registry of Patients With Skin Metastases From Breast Cancer Treated With Electrochemotherapy
This registry update reports the completion of a multicenter prospective registry evaluating skin metastases from breast cancer treated with…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer [NA]
This clinical trial aims to evaluate the effectiveness and safety of a single-port robotic-assisted subcutaneous gland resection with immedi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts [Phase 4]
A Phase 4 pharmacokinetic and pharmacogenomic study of ribociclib in race-based cohorts for breast cancer was terminated; results were poste…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive Patients
A clinical trial to evaluate de-escalation of neoadjuvant chemotherapy regimens with targeted therapy in HER2-positive breast cancer patient…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: FPA150 in Patients With Advanced Solid Tumors [EARLY_Phase 1]
This early-phase 1 trial of FPA150 in breast cancer, ovarian cancer, and endometrial cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy [NA]
This completed clinical trial evaluated patient-reported outcomes and physical activity in Japanese patients with HR+/HER2- advanced breast …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Effectiveness of a Modern Educational Intervention in Breast Cancer Patients [NA]
A clinical trial evaluated the effectiveness of a modern educational intervention for breast cancer patients, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer [NA]
The document provides a completed clinical trial update on the efficacy and safety of hyperbaric oxygen therapy for radiation dermatitis in …
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of durvalumab in combination with neoadjuvant chemotherapy for localized Luminal B HER2-negat…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment [Phase 2]
Phase 2 trial evaluating amyloid plaque deposition in chemotherapy-induced cognitive impairment among breast cancer patients was terminated,…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is assessing whether the nutritional supplement sulforaphane can protect against doxorubicin-related cardio…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application [NA]
This clinical trial update describes the feasibility of using a novel mobile application to address sexual dysfunction in women with breast …
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Sensorimotor Training Using Whole Body Vibration Exercise to Reduce Chemotherapy-induced Peripheral Neuropathy [NA]
Update on a completed trial evaluating sensorimotor training with whole body vibration to reduce chemotherapy-induced peripheral neuropathy …
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: OptiTrain - Optimal Training Women With Breast Cancer [NA]
OptiTrain, a trial studying optimal training for women with breast cancer, has completed. It evaluated well-being outcomes for participants,…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Exercise as Medicine for People With Cancer Sweden [NA]
A Swedish trial by Karolinska Institutet evaluating exercise as medicine for cancer has completed; it includes prostate cancer, breast cance…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and dosimetry of gallium-68 labelled OncoFAP derivatives in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations [Phase 2]
Phase 2 basket trial evaluating tucatinib in combination with trastuzumab across HER2-altered solid tumors, with results posted for several …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public [NA]
A terminated clinical trial in Malaysia evaluated a mobile health behavioural intervention to increase breast cancer screening rates among t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: GISEL:Registry of Breast Cancer Patients Treated With ECT
The GISEL registry tracking breast cancer patients treated with electrochemotherapy has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status [Phase 2]
A Phase II neoadjuvant trial in T1c operable, HER2-positive breast cancer defined by TOP2A status has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer [Phase 1]
This is a Phase 1 trial evaluating ipatasertib plus palbociclib and fulvestrant versus placebo plus palbociclib and fulvestrant in hormone r…